Clinical Trial Update: Effect of HCO1100 on Cardiovascular Function [NA]

View source ↗

Summary

Update on a terminated clinical trial evaluating HCO1100 for cardiovascular function in patients with cardiovascular disease and chronic kidney disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Chronic Kidney Disease

Drugs mentioned

• HCO1100 (HCO1100)

Snippet

Sponsor: Vantive Health LLC | Conditions: Cardiovascular Disease, Chronic Kidney Failure | NA | Status: TERMINATED